Yixintang Pharmaceutical Group Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Yixintang Pharmaceutical Group's earnings have been declining at an average annual rate of -2.9%, while the Consumer Retailing industry saw earnings growing at 3.5% annually. Revenues have been growing at an average rate of 12.1% per year. Yixintang Pharmaceutical Group's return on equity is 2.2%, and it has net margins of 0.9%.
Belangrijke informatie
-2.9%
Groei van de winst
-3.9%
Groei van de winst per aandeel
Consumer Retailing Groei van de industrie | 12.8% |
Inkomstengroei | 12.1% |
Rendement op eigen vermogen | 2.2% |
Nettomarge | 0.9% |
Laatste winstupdate | 30 Sep 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Market Cool On Yixintang Pharmaceutical Group Co., Ltd.'s (SZSE:002727) Earnings
Sep 25These 4 Measures Indicate That Yixintang Pharmaceutical Group (SZSE:002727) Is Using Debt Reasonably Well
Jul 15Some Investors May Be Worried About Yixintang Pharmaceutical Group's (SZSE:002727) Returns On Capital
Jun 29Yixintang Pharmaceutical Group Co., Ltd.'s (SZSE:002727) Intrinsic Value Is Potentially 26% Below Its Share Price
Jun 13Market Cool On Yixintang Pharmaceutical Group Co., Ltd.'s (SZSE:002727) Earnings Pushing Shares 27% Lower
Jun 13Yixintang Pharmaceutical Group (SZSE:002727) Is Due To Pay A Dividend Of CN¥0.40
May 27Yixintang Pharmaceutical Group's (SZSE:002727) Conservative Accounting Might Explain Soft Earnings
May 03Investors Holding Back On Yixintang Pharmaceutical Group Co., Ltd. (SZSE:002727)
Apr 15Return Trends At Yixintang Pharmaceutical Group (SZSE:002727) Aren't Appealing
Mar 06Opbrengsten en kosten
Hoe Yixintang Pharmaceutical Group geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
30 Sep 24 | 18,157 | 156 | 5,089 | 11 |
30 Jun 24 | 18,010 | 327 | 4,887 | 11 |
31 Mar 24 | 18,044 | 552 | 4,741 | 11 |
31 Dec 23 | 17,380 | 549 | 4,684 | 10 |
30 Sep 23 | 18,219 | 1,019 | 4,593 | 13 |
30 Jun 23 | 18,142 | 1,096 | 4,615 | 12 |
31 Mar 23 | 17,872 | 1,070 | 4,617 | 9 |
01 Jan 23 | 17,432 | 1,010 | 4,592 | 9 |
30 Sep 22 | 16,115 | 835 | 4,376 | 5 |
30 Jun 22 | 15,851 | 816 | 4,370 | 3 |
31 Mar 22 | 15,154 | 840 | 4,267 | 4 |
01 Jan 22 | 14,587 | 922 | 4,090 | 5 |
30 Sep 21 | 13,916 | 950 | 3,999 | 4 |
30 Jun 21 | 13,329 | 897 | 3,822 | 4 |
31 Mar 21 | 12,998 | 846 | 3,623 | 3 |
31 Dec 20 | 12,656 | 790 | 3,544 | 1 |
30 Sep 20 | 12,056 | 724 | 3,466 | 1 |
30 Jun 20 | 11,448 | 683 | 3,378 | 1 |
31 Mar 20 | 10,978 | 633 | 3,358 | 0 |
31 Dec 19 | 10,479 | 604 | 3,245 | 0 |
30 Sep 19 | 10,219 | 587 | 3,150 | 0 |
30 Jun 19 | 9,945 | 566 | 3,035 | 0 |
31 Mar 19 | 9,585 | 565 | 2,923 | 0 |
01 Jan 19 | 9,176 | 521 | 2,845 | 0 |
30 Sep 18 | 8,768 | 525 | 2,740 | 0 |
30 Jun 18 | 8,391 | 499 | 2,679 | 0 |
31 Mar 18 | 8,116 | 457 | 2,612 | 0 |
31 Dec 17 | 7,751 | 423 | 2,497 | 0 |
30 Sep 17 | 7,316 | 386 | 2,336 | 0 |
30 Jun 17 | 6,949 | 373 | 2,229 | 0 |
31 Mar 17 | 6,584 | 345 | 2,092 | 0 |
31 Dec 16 | 6,249 | 353 | 2,036 | 0 |
30 Sep 16 | 5,971 | 379 | 1,997 | 0 |
30 Jun 16 | 5,774 | 369 | 1,925 | 0 |
31 Mar 16 | 5,600 | 361 | 1,887 | 0 |
31 Dec 15 | 5,321 | 346 | 1,747 | 0 |
30 Sep 15 | 5,080 | 323 | 1,597 | 0 |
30 Jun 15 | 4,854 | 314 | 1,472 | 0 |
31 Mar 15 | 4,589 | 310 | 1,390 | 0 |
31 Dec 14 | 4,428 | 297 | 1,332 | 0 |
30 Sep 14 | 4,236 | 292 | 1,297 | 0 |
30 Jun 14 | 3,995 | 279 | 1,233 | 0 |
31 Mar 14 | 3,792 | 253 | 1,392 | 0 |
31 Dec 13 | 3,547 | 241 | 1,081 | 0 |
Kwaliteitswinsten: 002727 has a large one-off loss of CN¥92.9M impacting its last 12 months of financial results to 30th September, 2024.
Groeiende winstmarge: 002727's current net profit margins (0.9%) are lower than last year (5.6%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 002727's earnings have declined by 2.9% per year over the past 5 years.
Versnelling van de groei: 002727's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Winst versus industrie: 002727 had negative earnings growth (-84.7%) over the past year, making it difficult to compare to the Consumer Retailing industry average (6%).
Rendement op eigen vermogen
Hoge ROE: 002727's Return on Equity (2.2%) is considered low.